Cargando…

Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis

BACKGROUND: Research on the polymorphism of breast cancer (BC) helps to search the BC susceptibility gene for mass screening, early diagnosis, and gene therapy, which has become a hotspot in BC research field. Previous studies have suggested associations between rs11200014, rs2981579, and rs1219648...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yafei, Lu, Hongwei, Ji, Hong, Lu, Le, Liu, Pengdi, Hong, Ruofeng, Li, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815769/
https://www.ncbi.nlm.nih.gov/pubmed/29390357
http://dx.doi.org/10.1097/MD.0000000000009246
_version_ 1783300565552332800
author Zhang, Yafei
Lu, Hongwei
Ji, Hong
Lu, Le
Liu, Pengdi
Hong, Ruofeng
Li, Yiming
author_facet Zhang, Yafei
Lu, Hongwei
Ji, Hong
Lu, Le
Liu, Pengdi
Hong, Ruofeng
Li, Yiming
author_sort Zhang, Yafei
collection PubMed
description BACKGROUND: Research on the polymorphism of breast cancer (BC) helps to search the BC susceptibility gene for mass screening, early diagnosis, and gene therapy, which has become a hotspot in BC research field. Previous studies have suggested associations between rs11200014, rs2981579, and rs1219648 polymorphisms and cancer risk. The aim of this study was to evaluate the relationship between rs11200014, rs2981579, and rs1219648 polymorphism and BC risk. METHODS: PubMed, Web of science, and the Cochrane Library databases were searched before October 11, 2015, to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate the strength of associations. Sensitivity and subgroup analyses were conducted. All included cases should have been diagnosed by a pathological examination. RESULTS: Twenty-six studies published from 2007 to 2015 were included in this meta-analysis. The pooled results showed that there was a significant association between all the 3 variants and BC risk in any genetic model. When stratified by Source of controls, the results showed the same association between rs2981579 polymorphism and BC susceptibility in hospital-based (HB) group, although there was not any genetic model attained statistical correlation in population-based (PB) group. Subgroup analysis was performed on rs1219648 by ethnicity and Source of controls, and the effects remained in Asians, Caucasians, HB, and PB groups. CONCLUSION: This meta-analysis of case–control studies provides strong evidence that fibroblast growth factor 2 (FGFR2; rs11200014, rs2981579, and rs1219648) polymorphisms are significantly associated with the BC risk. For rs2981579, the association remained in hospital populations, while not in general populations. For rs1219648, the association remained in Asians, Caucasians, hospital populations, and general populations. However, further large-scale multicenter epidemiological studies are warranted to confirm this finding and the molecular mechanism for the associations need to be elucidated in future studies.
format Online
Article
Text
id pubmed-5815769
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58157692018-02-28 Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis Zhang, Yafei Lu, Hongwei Ji, Hong Lu, Le Liu, Pengdi Hong, Ruofeng Li, Yiming Medicine (Baltimore) 5700 BACKGROUND: Research on the polymorphism of breast cancer (BC) helps to search the BC susceptibility gene for mass screening, early diagnosis, and gene therapy, which has become a hotspot in BC research field. Previous studies have suggested associations between rs11200014, rs2981579, and rs1219648 polymorphisms and cancer risk. The aim of this study was to evaluate the relationship between rs11200014, rs2981579, and rs1219648 polymorphism and BC risk. METHODS: PubMed, Web of science, and the Cochrane Library databases were searched before October 11, 2015, to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate the strength of associations. Sensitivity and subgroup analyses were conducted. All included cases should have been diagnosed by a pathological examination. RESULTS: Twenty-six studies published from 2007 to 2015 were included in this meta-analysis. The pooled results showed that there was a significant association between all the 3 variants and BC risk in any genetic model. When stratified by Source of controls, the results showed the same association between rs2981579 polymorphism and BC susceptibility in hospital-based (HB) group, although there was not any genetic model attained statistical correlation in population-based (PB) group. Subgroup analysis was performed on rs1219648 by ethnicity and Source of controls, and the effects remained in Asians, Caucasians, HB, and PB groups. CONCLUSION: This meta-analysis of case–control studies provides strong evidence that fibroblast growth factor 2 (FGFR2; rs11200014, rs2981579, and rs1219648) polymorphisms are significantly associated with the BC risk. For rs2981579, the association remained in hospital populations, while not in general populations. For rs1219648, the association remained in Asians, Caucasians, hospital populations, and general populations. However, further large-scale multicenter epidemiological studies are warranted to confirm this finding and the molecular mechanism for the associations need to be elucidated in future studies. Wolters Kluwer Health 2017-12-15 /pmc/articles/PMC5815769/ /pubmed/29390357 http://dx.doi.org/10.1097/MD.0000000000009246 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 5700
Zhang, Yafei
Lu, Hongwei
Ji, Hong
Lu, Le
Liu, Pengdi
Hong, Ruofeng
Li, Yiming
Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis
title Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis
title_full Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis
title_fullStr Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis
title_full_unstemmed Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis
title_short Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis
title_sort association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: a meta-analysis
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815769/
https://www.ncbi.nlm.nih.gov/pubmed/29390357
http://dx.doi.org/10.1097/MD.0000000000009246
work_keys_str_mv AT zhangyafei associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis
AT luhongwei associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis
AT jihong associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis
AT lule associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis
AT liupengdi associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis
AT hongruofeng associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis
AT liyiming associationbetweenrs11200014rs2981579andrs1219648polymorphismandbreastcancersusceptibilityametaanalysis